The drugs industry is an enormous multibillion businesses encompassing an immense number of companies involved in the design, production and marketing of drugs worldwide. According to the type of drugs the market can be dived into the following segments: diabetes, antifungal, antidepressant, antithrombotic, hepatitis drugs, analgesics and a far more.
Currently, the drugs market is undergoing a recovery phase in the wake of the recent decline provoked by the economic slump. The market growth is spurred by increasing demand for drugs across the globe, rising incidence of chronic as well as infectious diseases, population ageing, product innovations and constant technological advancements. North America and Europe are the most prominent regional markets. Bristol-Myers Squibb, Pharmacia, GlaxoSmithKline, Merck & Co, Novartis, Eli Lilly, Pfizer, Johnson & Johnson, Allergan, Schering-Plough, Bayer and Abbott Labs are amid global drugs arena giants.
A huge collection of the research reports covering the drugs market at different geographies can be found under this MarketPublishers’ catalogue. The researches provide comprehensive assessment of the market, characterize major market trends and disclose essential market indicators. The reports describe the competitive scenario and indicate top market players. In addition, future prospects for the drugs market are thoroughly studied in the research reports.
Publications found:
8,499
Sort by:
Non-Small-Cell Lung Carcinoma (NSCLC) - Pipeline Insight, 2021
US$ 1,500.00
... and chemical information Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Non-Small Cell Lung Cancer The report also ...
February 2021
60 pages
Graves Ophthalmopathy - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 48-72 Hours DelveInsight’s, “Graves Ophthalmopathy - Pipeline Insight, 2021,” report provides comprehensive insights about 3+ companies and 3+ pipe...
February 2021
60 pages
IgA Nephropathy- Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 48-72 Hours DelveInsight’s, “IgA Nephropathy – Pipeline Insight, 2021,” report provides comprehensive insights about 10+ companies and 10+ pipeline...
February 2021
60 pages
MALT Lymhoma - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 48-72 Hours DelveInsight’s, “Mucosa-associated Lymphoid Tissue (MALT) Lymphoma – Pipeline Insight, 2021,” report provides comprehensive insights ab...
February 2021
60 pages
Mild To Moderate Plaque Psoriasis - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 48-72 Hours DelveInsight’s, “Mild To Moderate Plaque Psoriasis - Pipeline Insight, 2021,” report provides comprehensive insights about 4+ companies...
February 2021
60 pages
Postoperative pain - Pipeline Insight, 2021
US$ 2,500.00
This report can be delivered to the clients within 2-3 Business Days DelveInsight’s, “Postoperative pain - Pipeline Insight, 2021,” report provides comprehensive insights about 60+ companies and 60+...
February 2021
200 pages
ACALABRUTINIB - Emerging Insight and Market Forecast - 2030
US$ 3,250.00
This report can be delivered to the clients within 48 Hours “ACALABRUTINIB - Emerging Insight and Market Forecast - 2030” the report provides comprehensive insights about an investigational product...
February 2021
30 pages
Aliqopa - Drug Insight and Market Forecast - 2030
US$ 2,750.00
This report can be delivered to the clients within 48 Hours OVERVIEW “Aliqopa - Drug Insight and Market Forecast - 2030” report by DelveInsight outlays comprehensive insights of the product indicate...
February 2021
30 pages
ARIMOCLOMOL - Emerging Insight and Market Forecast - 2030
US$ 3,250.00
This report can be delivered to the clients within 48 Hours “ARIMOCLOMOL - Emerging Insight and Market Forecast - 2030” the report provides comprehensive insights about an investigational product fo...
February 2021
30 pages
ATEZOLIZUMAB - Emerging Insight and Market Forecast - 2030
US$ 3,250.00
This report can be delivered to the clients within 48 Hours “ATEZOLIZUMAB - Emerging Insight and Market Forecast - 2030” the report provides comprehensive insights about an investigational product f...
February 2021
30 pages
BI 764524 - Emerging Insight and Market Forecast - 2030
US$ 3,250.00
This report can be delivered to the clients within 48 Hours “BI 764524 - Emerging Insight and Market Forecast - 2030” the report provides comprehensive insights about an investigational product for...
February 2021
30 pages
BLINATUMOMAB - Emerging Insight and Market Forecast - 2030
US$ 3,250.00
This report can be delivered to the clients within 48 Hours “BLINATUMOMAB - Emerging Insight and Market Forecast - 2030” the report provides comprehensive insights about an investigational product f...
February 2021
30 pages
DB-102 - Emerging Insight and Market Forecast - 2030
US$ 3,250.00
This report can be delivered to the clients within 48 Hours “DB-102 - Emerging Insight and Market Forecast - 2030” the report provides comprehensive insights about an investigational product for Dif...
February 2021
30 pages
RG 7774 - Emerging Insight and Market Forecast - 2030
US$ 3,250.00
This report can be delivered to the clients within 48 Hours “RG 7774 - Emerging Insight and Market Forecast - 2030” the report provides comprehensive insights about an investigational product for Di...
February 2021
30 pages
TREAKISYM - Emerging Insight and Market Forecast - 2030
US$ 3,250.00
This report can be delivered to the clients within 48 Hours “TREAKISYM - Emerging Insight and Market Forecast - 2030” the report provides comprehensive insights about an investigational product for...
February 2021
30 pages
VENGLUSTAT - Emerging Insight and Market Forecast - 2030
US$ 3,250.00
This report can be delivered to the clients within 48 Hours “VENGLUSTAT - Emerging Insight and Market Forecast - 2030” the report provides comprehensive insights about an investigational product for...
February 2021
30 pages
Zydelig - Drug Insight and Market Forecast - 2030
US$ 2,750.00
This report can be delivered to the clients within 48 Hours OVERVIEW “Zydelig - Drug Insight and Market Forecast - 2030” report by DelveInsight outlays comprehensive insights of the product indicate...
February 2021
30 pages
Abnormal Glucose tolerance-Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 48-72 Hours DelveInsight’s, “Abnormal Glucose Tolerance – Pipeline Insight, 2021,” report provides comprehensive insights about 5+ companies and 5+...
February 2021
60 pages
Advanced Urotheilal carcinoma - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 48-72 Hours DelveInsight’s, “Advanced Urothelial Carcinoma – Pipeline Insight, 2021,” report provides comprehensive insights about 10+ companies an...
February 2021
60 pages
Alpha Thalassemia - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 48-72 Hours DelveInsight’s, “Alpha Thalassemia – Pipeline Insight, 2021,” report provides comprehensive insights about 4+ companies and 4+ pipeline...
February 2021
60 pages
Chronic Otitis Media (COM) - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 48-72 Hours DelveInsight’s, “Chronic Otitis Media (COM) - Pipeline Insight, 2021,” report provides comprehensive insights about 3+ companies and 3+...
February 2021
60 pages
Chronic Pulmonary Infections - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 48-72 Hours DelveInsight’s, “Chronic Pulmonary Infections - Pipeline Insight, 2021,” report provides comprehensive insights about 10+ companies and...
February 2021
60 pages
Chronic Traumatic Encephalopathy - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 48-72 Hours DelveInsight’s, “Chronic Traumatic Encephalopathy - Pipeline Insight, 2021,” report provides comprehensive insights about 3+ companies...
February 2021
60 pages
Diabetic Cardiomyopathy - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 48-72 Hours DelveInsight’s, “Diabetic Cardiomyopathy - Pipeline Insight, 2021,” report provides comprehensive insights about 3+ companies and 3+ pi...
February 2021
60 pages
Diabetic Ketoacidosis - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 48-72 Hours DelveInsight’s, “Diabetic Ketoacidosis - Pipeline Insight, 2021,” report provides comprehensive insights about 3+ companies and 3+ pipe...
February 2021
60 pages
Egg allergy - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 48-72 Hours DelveInsight’s, “Egg allergy - Pipeline Insight, 2021,” report provides comprehensive insights about 3+ companies and 3+ pipeline drugs...
February 2021
60 pages
Endocarditis - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 48-72 Hours DelveInsight’s, “Endocarditis – Pipeline Insight, 2021,” report provides comprehensive insights about 4+ companies and 4+ pipeline drug...
February 2021
60 pages
ER+/ HER2 -ve Breast Cancer - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 48-72 Hours DelveInsight’s, “ER+/ HER2 -ve Breast Cancer - Pipeline Insight, 2021,” report provides comprehensive insights about 5+ companies and 5...
February 2021
60 pages
Excessive Daytime Sleepiness - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 48-72 Hours DelveInsight’s, “Excessive Daytime Sleepiness - Pipeline Insight, 2021,” report provides comprehensive insights about 10+ companies and...
February 2021
60 pages
Familial Mediterranean Fever - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 48-72 Hours DelveInsight’s, “Familial Mediterranean Fever - Pipeline Insight, 2021,” report provides comprehensive insights about 3+ companies and...
February 2021
60 pages
Gout - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 48-72 Hours DelveInsight’s, “Gout - Pipeline Insight, 2021,” report provides comprehensive insights about 5+ companies and 5+ pipeline drugs in Gou...
February 2021
60 pages
Hedgehog Pathway Inhibitors - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 48-72 Hours DelveInsight’s, “Hedgehog Pathway Inhibitors - Pipeline Insight, 2021,” report provides comprehensive insights about 10+ companies and...
February 2021
60 pages
Hodgkin’s Lymphoma – Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 48-72 Hours DelveInsight’s, “Hodgkin’s Lymphoma - Pipeline Insight, 2021,” report provides comprehensive insights about 10+ companies and 10+ pipel...
February 2021
60 pages
Inflammatory Pain - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 48-72 Hours DelveInsight’s, “Inflammatory Pain - Pipeline Insight, 2021,” report provides comprehensive insights about 3+ companies and 3+ pipeline...
February 2021
60 pages
Inter Alpha Inhibitor Proteins - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 48-72 Hours DelveInsight’s, “Inter Alpha Inhibitor Proteins – Pipeline Insight, 2021,” report provides comprehensive insights about 3+ companies an...
February 2021
60 pages
